dc.contributor.author | Fernández Martínez, Tomas Eduardo | es |
dc.date.accessioned | 2014-06-24T21:38:10Z | |
dc.date.available | 2014-06-24T21:38:10Z | |
dc.date.issued | 2013 | es |
dc.identifier.citation | Ponce-Monter, H., Ortiz, Mario I., Fernández-Martínez, E., Soria-Jasso L.E., Téllez-Téllez, G., Martínez-Corona, M., González-Ramírez, P., Romero-Quezada, L.C., Veras-Godoy, H.A. (2013). Prevalence, impact and treatment of primary dysmenorrhea in workers of an academic and research institute. Mexican Journal of Medical Research, 1. | es |
dc.identifier.uri | https://repository.uaeh.edu.mx/bitstream/handle/123456789/15278 | |
dc.description.abstract | Dysmenorrhea is one of the cyclical processes in chronic pelvic pain. Dysmenorrhea in women causes a high psychosocial and economic impact. For this reason, we conducted a study to assess the prevalence, impact and use of drugs for the treatment of dysmenorrhea among workers of an Educational and Research Institute. A prevalence of dysmenorrhea of 57.2% was found. About a half (49.4%) of women with dysmenorrhea reported that it limited their daily activities in 4.1 ± 2.4 cycles per year. 29.3% reported absenteeism by at least 2.7 ± 1.4 (range 1-5) cycles per year. Of the women with dysmenorrhea, only 34.9% consulted a doctor and the most prescribed drugs were over the counter medications with metamizol and butylscopolamine (25.0%), another medicine with paracetamol, pamabrom and pyrilamine (Syncol®, 16.7%) naproxen (12.5%) and mefenamic acid (12.5%). On the other hand, self-medication was practiced by 54.2% of women with dysmenorrhea and the most used drugs were Syncol® (28.9%), naproxen (17.8%), metamizol with butylscopolamine (13.3%) and dipyrone (6.7%). Our data suggest a significant prevalence of primary dysmenorrhea and dysmenorrheic women used many drugs for self-medication, but rarely come to medical services. | es |
dc.language | es | es |
dc.subject | Farmacología de la Reproducción y Analgesia inducida por neuroesteroides y AINES | es |
dc.title | Prevalence, impact and treatment of primary dysmenorrhea in workers of an academic and research institute. | es |
dc.type | Article | es |